Results 1 to 10 of about 31,215 (276)

Biomarkers of Electronic Nicotine Delivery Systems (ENDS) use [PDF]

Addiction Neuroscience, 2023
This perspective summarizes available evidence on biomarkers of exposure in electronic nicotine delivery system (ENDS) users to aid the overall assessment of the health consequences of using ENDS.
Maciej L. Goniewicz
doaj   +4 more sources

Electronic Nicotine Delivery Systems (ENDS): Implications for the Clinician [PDF]

Pulmonary Therapy
The evidence that tobacco cigarettes are harmful to the health of smokers led to the introduction of electronic nicotine delivery systems (ENDS) as a safer alternative.
Jean-Guillaume Starnini, Giulio Natalello, Federico Nigroli, Chiara Diana, Elena Bargagli, Andrea Sisto Melani   +5 more
doaj   +2 more sources

Using Electronic Nicotine Delivery Systems as a Smoking Cessation Method in Al-Baha City, Saudi Arabia: A Community-based Qualitative Study

King Khalid University Journal of Health Sciences
Background: Smoking remains a significant public health problem in Saudi Arabia. Reports from the Saudi Food and Drug Authority showed an increasing prevalence of smoking among adult population.
Yousef Zahrani, Ibrahim Al Ghamdi
doaj   +2 more sources

Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health. [PDF]

Circ Res, 2023
The use of electronic nicotine delivery systems, specifically electronic cigarettes (e-cig), has risen dramatically within the last few years; the demographic purchasing these devices is now predominantly adolescents that are not trying to quit the use of traditional combustible cigarettes, but rather are new users.
Mears MJ, Hookfin HL, Bandaru P, Vidal P, Stanford KI, Wold LE.   +5 more
europepmc   +3 more sources

Randomized clinical studies assessing the pharmacokinetics and subjective effects of vuse alto electronic nicotine delivery systems. [PDF]

Sci Rep
Prevette K, Jordan KG, Keyser BM, Kanobe MN, Jin T, Ayoku S, Darnell J, Makena P, Baxter SA.   +8 more
europepmc   +3 more sources

Types of electronic nicotine delivery systems (ENDS) used by people of different age and smoking status groups: results from a US nationally representative survey. [PDF]

BMJ Open
Massey ZB, Fairman RT, Cham B, Alqahtani M, Luo R, Weaver S, Popova L, Ashley DL.   +7 more
europepmc   +3 more sources

Use of Electronic Nicotine Delivery Systems and Age of Asthma Onset Among US Adults and Youths. [PDF]

JAMA Netw Open
Pérez A, Valencia S, Jani PP, Harrell MB.   +3 more
europepmc   +2 more sources

Electronic nicotine delivery systems [PDF]

European Respiratory Journal, 2015
We thank K. Nackaerts and L. Joossens for correctly pointing out an error in our editorial “Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?” [1]. Where the Editorial states that “there will be a maximum nicotine volume for e-cigarettes (2 mL for single use and 10 mL for refillable cartridges), and a ...
Francesco, Blasi, Brian, Ward
  +10 more sources

FDA Regulation of Electronic Nicotine Delivery Systems and the “Deeming” Rule: What’s Left for States? [PDF]

, 2018
William Tilburg, Kathleen Hoke, Mellissa Sager   +2 more
openalex   +3 more sources

Fluctuation between cigarette smoking and use of electronic nicotine delivery systems: Impact on clozapine concentrations and clinical effect [PDF]

Mental Health Clinician, 2021
Unlike with smoking cigarettes, electronic nicotine delivery systems do not cause CYP450 1A2 induction as there is a lack of combustion and polycyclic aromatic hydrocarbon production.
Montville Daniel J. MD, Lindsey Jaclyn M. MD, Leung Jonathan G. PharmD   +2 more
doaj   +1 more source